REPH - Recro Pharma Inc
Close
2.09
-0.010 -0.478%
Share volume: 141,803
Last Updated: Mon 21 Mar 2022 09:00:01 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$2.10
-0.01
-0.48%
Summary score
43%
Profitability
53%
Dept financing
21%
Liquidity
55%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0.2%
Return on assets
-3.61%
Return on sales
-32.53%
Return on invested capital
-19.5%
Total debt ratio
90.36%
Debt ratio change over timeo
-11.06%
Current Ratio
4.18%
Quick Ratio
3.58%
Cash Position Ratio
1.65%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
41.25%
Return on assets
0.17%
Return on sales
2.19%
Return on invested capital
-13.89%
Total debt ratio
112.54%
Debt ratio change over timeo
-20.03%
Current Ratio
6.22%
Quick Ratio
5.07%
Cash Position Ratio
1.93%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
39.01%
Return on assets
-0.47%
Return on sales
-3.23%
Return on invested capital
-16.64%
Total debt ratio
114.38%
Debt ratio change over time
-6.91%
Current Ratio
4.45%
Quick Ratio
3.55%
Cash Position Ratio
1.75%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-194.09%
Return on assets
-79.51%
Return on sales
99%
Return on invested capital
49.64%
Total debt ratio
-1106.38%
Debt ratio change over time
-11.06%
Current Ratio
-63.31%
Quick Ratio
-54.39%
Cash Position Ratio
-21.46%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | REPH | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 0.2% | 0% | 0% | 29.06% |
| Return on assets | -3.61% | 0% | 0% | -9.75% |
| Return on sales | -32.53% | 0% | 0% | -1469.44% |
| Return on invested capital | -19.5% | 0% | 0% | 47.78% |
| Profitability | 0% | 0% | 50% | 50% |
| Total debt ratio | 90.36% | 0% | 0% | 183.15% |
| Debt ratio change over time | -11.06% | 0% | 0% | 19.02% |
| Dept financing | 12% | 0% | 0% | 50% |
| Current Ratio | 6.22% | 0% | 0% | 5.9% |
| Quick Ratio | 5.07% | 0% | 0% | 5.9% |
| Cash Position Ratio | 1.93% | 0% | 0% | 5.68% |
| Liquididy | 54% | 0% | 0% | 74% |
| Short-term ratios | REPH | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 41.25% | 0% | 0% | -16.12% |
| Return on assets | 0.17% | 0% | 0% | -14.95% |
| Return on sales | 2.19% | 0% | 0% | -3498.94% |
| Return on invested capital | -13.89% | 0% | 0% | 96.56% |
| Profitability | 75% | 0% | 0% | 25% |
| Total debt ratio | 112.54% | 0% | 0% | 79.61% |
| Debt ratio change over time | -20.03% | 0% | 0% | 0.09% |
| Dept financing | 25% | 0% | 0% | 43% |
| Current Ratio | 6.22% | 0% | 0% | 5.9% |
| Quick Ratio | 5.07% | 0% | 0% | 5.9% |
| Cash Position Ratio | 1.93% | 0% | 0% | 5.68% |
| Liquididy | 55% | 0% | 0% | 74% |